Instalab
logoInstalab

Urine Volume (Preserved)

24 Hour Urine Test
One of the clearest signals of how much working kidney capacity you have, often missed by routine blood tests.

Should you take a Urine Volume (Preserved) test?

This test is most useful if any of these apply to you.

Forming Kidney Stones Repeatedly
This test reveals whether your urine output is hitting the level shown to lower stone recurrence and helps target prevention strategies that work.
Already Managing Kidney Issues
If you have CKD, are on dialysis, or have polycystic kidney disease, this number tracks how much real kidney function you still have.
Living with Diabetes or Heart Failure
For anyone on SGLT2 inhibitors, diuretics, or tolvaptan, this test shows whether the drug is producing the expected kidney effect.
Healthy and Tracking Kidney Aging
Higher 24-hour urine volume is linked to slower kidney decline over years, making it a useful baseline marker for prevention-focused adults.

About Urine Volume (Preserved)

Most lab tests give you a snapshot. A 24-hour urine collection gives you something different: a direct accounting of what your kidneys actually produced over a full day, in real working conditions.

That total volume tracks survival, kidney decline, and stone risk in ways a single blood draw cannot. Lower volumes have been linked to higher death rates in critical illness and dialysis, faster kidney function loss in the general population, and a much higher chance of forming new kidney stones.

What 24-Hour Urine Volume Actually Reflects

The number is simple, but what shapes it is not. Volume reflects three forces working together: how much fluid you take in, how well your kidneys filter that fluid, and how strongly hormones tell your kidneys to hold water back or let it go.

In people on dialysis, this one number reveals how much native kidney function remains. In healthy people, it reveals whether your habitual hydration and kidney handling are producing enough output to protect long-term filtering capacity.

Kidney Function and Survival on Dialysis

In a study of 1,946 dialysis patients, higher residual urine volume was strongly associated with lower risk of death. Adding urine volume to standard kidney function estimates significantly improved survival predictions, performing better than eGFR (estimated glomerular filtration rate, a calculated kidney filtering score from blood markers) used alone.

A separate study of 387 hemodialysis patients found that higher residual kidney function during the first 2 years of dialysis was associated with better survival, with urine volume at any time point predicting outcomes. In peritoneal dialysis, urine volume also strongly correlates with how much urea, creatinine, and phosphorus the kidneys still clear on their own.

Sepsis and Critical Illness

In 7,218 ICU patients with sepsis, 24-hour urine volume on the first day predicted 28-day survival. The relationship was not a straight line: each additional 50 mL of urine output reduced mortality risk by about 1%, with the steepest benefit at the lowest volumes.

Below roughly 1.7 liters per day, more output meant clearly better survival. Above that point, the benefit flattened. The takeaway is simple: in acute illness, low urine output is one of the earliest and strongest signals that kidneys are in trouble, often before blood creatinine moves.

Kidney Stone Risk

Low urine volume is one of the strongest changeable risk factors for kidney stones. Stone formers consistently produce less urine than people who have never formed stones, and this is true across the full range of dietary and metabolic backgrounds.

Stone prevention programs typically target 2.5 liters or more per day. A meta-analysis of fluid intake interventions found that high fluid intake significantly reduced both first-time and recurrent kidney stones. In a study of 688 active stone formers, repeat 24-hour collections taken 6 months apart significantly improved urinary stone risk parameters over time, suggesting that this number responds to sustained behavior change.

Long-Term Kidney Health in the General Population

In a community study of 2,148 adults with normal baseline kidney function, those producing 3 liters or more per day had slower decline in eGFR over 6 years compared with those producing less than 1 liter. The difference was meaningful at the population level.

This is not about chugging water on demand. It is about whether your habitual hydration and kidney handling together produce enough output to support filtering capacity over decades.

When Higher Is Not Always Better

Very high volumes can also signal trouble. In ICU patients with acute respiratory distress and severe COPD (chronic obstructive pulmonary disease, a long-term lung condition) flares, the relationship between urine output and short-term mortality is U-shaped: both very low and very high volumes raised risk.

This is not a contradiction. 24-hour urine volume is not a number where bigger always wins. It is a window into how your kidneys handle water and waste. Low volumes signal failing kidneys, dehydration, or acute illness. Extreme polyuria (very high output) can signal hormonal disorders, uncontrolled diabetes, drug effects, or polycystic kidney disease. The middle range, roughly 1.5 to 3 liters in healthy adults, is where most metabolic safety sits.

Reference Ranges

These ranges come from clinical and research literature, including a German biomonitoring program of young adults that treated 700 to 4,000 mL per day as a plausible valid collection range. They vary by population, lab, and clinical context, and are orientation, not absolute targets.

RangeLabelWhat It Suggests
50 mL or lessAnuriaSevere acute kidney injury or end-stage kidney failure
50 to 400 mLOliguriaAcute kidney stress, severe dehydration, or failing kidneys
1,000 to 2,000 mLTypical adultGenerally adequate kidney function and hydration
2,500 mL or moreStone prevention targetVolume associated with lower kidney stone recurrence
More than 4,000 mLHigh output / polyuriaOften desirable for stone prevention, but extreme values warrant evaluation

Source: Lin et al. 2024 (sepsis cutoffs); Conroy et al. 2024 (stone prevention targets); Lermen et al. 2019 (biomonitoring validity range). Compare your results within the same lab over time for the most meaningful trend.

When Results Can Be Misleading

The biggest single issue with this test is collection accuracy. Studies have repeatedly found high rates of incomplete 24-hour collections, with missed voids being the most common error. A falsely low volume can be due entirely to a missed bathroom trip rather than any kidney problem.

  • Incomplete collection: missing even one void can drop the total significantly. Most labs verify completeness by checking 24-hour creatinine output against your expected production based on body size.
  • Unusual fluid intake the day of collection: a 24-hour volume reflects what you drank that day, not your usual pattern. Heavy water consumption or significant restriction will distort the result.
  • Recent intense exercise or heat exposure: vasopressin (the hormone that tells kidneys to hold water) spikes during dehydration, concentrating urine and lowering volume for hours afterward.
  • Acute illness or recent surgery: surgical stress and acute infection can transiently raise vasopressin and lower output, even when long-term kidney function is fine.

Tracking Your Trend

A single 24-hour collection captures one day, and one day can be unusual. Repeat 24-hour collections in healthy adults show moderate stability over years (intraclass correlation 0.67, where 1.0 would mean perfect repeatability and 0 would mean random).

For stone formers, two 24-hour collections are considered optimal: a single collection changed clinical decisions in up to 45% of patients in one study of 813 stone formers. For people on dialysis tracking residual kidney function, more frequent measurement (every 1 to 3 months) is standard.

If you are using this test for prevention or to monitor a treatment, get a baseline, repeat in 3 to 6 months if you are making changes, then test at least annually. Trends matter more than any one reading.

What an Abnormal Result Should Make You Do

If your volume is low (under 1 liter per day) and not explained by low water intake, look at companion tests: serum creatinine, cystatin C, and eGFR for kidney filtering function; urine albumin-to-creatinine ratio for early kidney damage; and 24-hour urine creatinine to verify the collection was actually complete. A low volume alongside rising creatinine or albumin is worth investigating with a nephrologist.

If your volume is high (over 3 liters per day) without aggressive hydration, check fasting glucose and HbA1c (a 3-month average of blood sugar), since high blood sugar can drive osmotic diuresis. Review your medication list for SGLT2 inhibitors, diuretics, or vasopressin-blocking drugs. Persistent unexplained polyuria may warrant endocrine evaluation for diabetes insipidus or related hormone problems.

For stone formers, pair urine volume with a full 24-hour stone risk panel covering calcium, oxalate, citrate, uric acid, sodium, and magnesium. Volume alone tells you whether you are diluting your urine; the solute panel tells you what you need to dilute.

What Moves This Biomarker

Evidence-backed interventions that affect your Urine Volume (Preserved) level

↑ Increase
Increase daily water intake
Drinking more water is the most direct way to raise your 24-hour urine volume, and it is the only intervention with strong evidence for reducing kidney stone recurrence. In adolescent stone formers, each additional liter of daily water intake produced about 710 mL more 24-hour urine output. A meta-analysis of fluid intake trials found high water intake significantly lowered both first-time and recurrent kidney stones, with stone prevention guidelines targeting 2.5 liters or more of urine per day.
LifestyleStrong Evidence
↑ Increase
Tolvaptan (vasopressin V2 receptor antagonist) for ADPKD
Tolvaptan blocks the hormone that tells your kidneys to concentrate urine, causing very large increases in 24-hour volume. In autosomal dominant polycystic kidney disease (ADPKD, an inherited condition that causes kidney cysts), tolvaptan can raise 24-hour urine volume from about 2.6 L to nearly 6 L, slowing cyst growth and kidney decline. The polyuria is the intended mechanism, not a side effect, but it is what limits how many people can tolerate the drug long-term.
MedicationStrong Evidence
↑ Increase
Loop diuretics for acute heart failure congestion
Loop diuretics directly drive the kidneys to release more water and sodium, which is the goal when treating fluid overload from heart failure. In a randomized trial of 160 patients with acute heart failure and kidney dysfunction, a higher furosemide dose guided by the cardiac biomarker CA125 (a protein released from heart and lung tissue) significantly increased 72-hour urine output compared with usual care. The volume increase reflects therapeutic decongestion of fluid-overloaded tissues.
MedicationStrong Evidence
↑ Increase
SGLT2 inhibitors (empagliflozin, dapagliflozin, others)
This class of diabetes and heart failure drugs causes the kidneys to excrete more glucose, which pulls water along with it. In a randomized trial of 23 type 2 diabetes patients with chronic heart failure, the SGLT2 inhibitor empagliflozin significantly increased 24-hour urine volume without increasing sodium loss when added to loop diuretics. In an observational study of 1,306 stone formers, those on SGLT2 inhibitors had higher mean 24-hour urine volume (2.4 vs 2.0 L per day) and higher urine citrate, both of which lower stone risk.
MedicationModerate Evidence

Frequently Asked Questions

References

27 studies
  1. Belcher J, Coyle D, Lindley EJ, Keane DF, Caskey F, Dasgupta I, Davenport a, Farrington K, Mitra S, Ormandy P, Wilkie M, Macdonald J, Solis-trapala I, Sim J, Davies SJKidney3602024
  2. Lee MJ, Park JT, Park KS, Kwon YE, Oh HJ, Yoo TH, Kim YL, Kim YS, Yang CW, Kim NH, Kang SW, Han SHClinical Journal of the American Society of Nephrology2017
  3. Clark WF, Sontrop JM, Macnab JJ, Suri RS, Moist L, Salvadori M, Garg AXClinical Journal of the American Society of Nephrology2011